UAEM Evidence

  • SUBMIT
  • About
  • All posts (hover for categories)
    • Access Gap
    • UAEM Basic references
    • Excessive IP
    • Pharma general
    • Patents VS Innovation
    • Research Gap
    • NTDs
    • Trans-Pacific Partnership Agreement
    • Universities vs Industry
    • Patenting living organisms
  • Bookmarklet
A place for all useful evidence to come together.

Category Trans-Pacific Partnership Agreement

Dealing with intellectual property issues linked to affordability and access to medicines, included in the WHO Essential Medicines List (EML).

May 16, 2016 · by uaemevidence · in Access Gap, Excessive IP, Patenting living organisms, Pharma in politics, Trans-Pacific Partnership Agreement, TRIPS+ · Leave a comment

Advertisements

USTR Special 301 report (still) criticising use of TRIPS flexibilities

November 14, 2013 · by uaemevidence · in Access Gap, Excessive IP, Trans-Pacific Partnership Agreement · Leave a comment

TPP seeks to prevent access to trial data

October 25, 2013 · by uaemevidence · in Trans-Pacific Partnership Agreement · Leave a comment

TPP wants customs officials to seize goods even if just in transit when they are ‘confusingly similar’ to trademarked products

October 25, 2013 · by uaemevidence · in Trans-Pacific Partnership Agreement · Leave a comment

TPP makes it harder to oppose patent grants

October 25, 2013 · by uaemevidence · in Trans-Pacific Partnership Agreement · Leave a comment

TPP seeks to allow patenting of medical *methods*

October 25, 2013 · by uaemevidence · in Excessive IP, Patenting living organisms, Trans-Pacific Partnership Agreement · Leave a comment

Humanitarian NGOs rely on generics

October 19, 2013 · by uaemevidence · in Access Gap, Trans-Pacific Partnership Agreement, UAEM Basic references · Leave a comment
← Older posts

CONTACT

uaemevidence@gmail.com

SEARCH

Categories

  • Access Gap (34)
  • Arguments from Pharma (10)
  • De-linkage examples (3)
  • Excessive IP (16)
  • GAL – examples in practice (2)
  • NTDs (10)
  • Open Science – examples (2)
  • Patenting living organisms (8)
  • Patents VS Innovation (16)
  • Pharma general (31)
  • Pharma in politics (2)
  • Research Gap (14)
  • SRL (3)
  • Trans-Pacific Partnership Agreement (8)
  • TRIPS+ (4)
  • UAEM Basic references (22)
  • UAEM-authored (5)
  • Uncategorized (8)
  • Universities vs Industry (13)

Enter your email address to follow this blog and receive notifications of new posts by email.

Blog at WordPress.com.
UAEM Evidence
Create a free website or blog at WordPress.com.
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
Cancel